Sionna Stock 144% This Year: Is the Biotech a Buy Now?
Sionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
Explore the top cash back cards that provide the highest rewards. Learn how to maximize your earnings with these fantastic options.
26,275 articlesSionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
A little-known micro-cap trading under $30 is drawing renewed investor interest as quarterly results show improving p...
SpaceX gears up for the largest IPO in history on Nasdaq, while a 1:1 tokenized SpaceX equity trades on Solana. Backp...
Oil is rising and energy stocks are drawing cautious buyers. This guide shows two resilient oil producers you could b...
The S&P 500 has momentum, but not every stock is priced to perfection. These dividend stocks stand out for income...
Income investors are eyeing bristol myers squibb's 4.3% yield, but a high payout begs questions about safety. This ar...
Two high-value online gold deals ended with counterfeit $100 bills and a fraud investigation. Learn how these scams w...
Two very different computer vision players sit at automation's frontier. This guide weighs Aeva Technologies and Cogn...
A beginner-friendly look at how big investment moves in real estate investment trusts signal risk and income opportun...
In a choppy market, one defense contractor shines as a rare dividend stock built for downturns. Its government-backed...
BrightSpring’s latest earnings call shed light on growth trends, margin discipline, and a cautious yet hopeful outloo...
Tech stocks have cooled, but Meta Platforms may offer a patient investor a compelling setup. This guide breaks down w...